Fetal cells from cord blood as stem cell source: current status and possible implications in gynaecologic oncology

Umbilical cord blood is increasingly used as a source of hematopoietic stem cells for transplantation. Due to recent success, cord blood banks are being set up. We reviewed the currently available literature concerning cord blood collection, storage and transplantation, the impact of prenatal and perinatal factors and collection techniques on the quantity and quality of cord blood, and the ethical, legal and social questions related to cord blood transplantation. Possible implications in gynecologic oncology are reviewed and discussed. The emerging therapeutic use of cord blood for transplantation and transfusion implies new challenges for the speciality of gynecology and obstetrics.

Cord blood; Hematopoietic stem cells; Transplantation

[1] Broxmeyer H. E., DouglasG . W.,H angoc C.,C ooper S., Bard J.,E nglish D. et al.: "Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells". Proc. Natl. Acad. Sci USA, 1989, 86, 3828.

[2] Tavassoli M.: "Embryonic and fetal hematopoiesis". Blood Cells, 1991, 17 269.

[3] TavianM .,C oulombcl L.,L uton D., San ClementeH ., Dieterlen-Lievre F., Peault B.: " Aorta-associated CD34+ hemotopoietic cells in the early human embryo". Blood, 1996, 87, 67.

[4] Thompson C.: " Umb山cal cords: turning garbage into clinical gold". Science, 1995, 268, 805.

[5] Cairo M. S., Wagner J.E.: "Placental and/or umbilical cord blood: An alternative source of hematopoietic stern cells for transplantation". Blood, 1997, 90, 4665.

[6] Rocha V., Wagner J. E., Sobocinski K. A., Klein J. P., ZhangM . J.,H orowitz M.M .,G luckmanE .: "Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling". N. Engl. J. Med., 2000, 342, 1846.

[7] Cohen S. B. A., Dominiguez E., Lowdell M., Madrigal J. A.:'The immunological properties of cord blood: overview of current research presented at the 2nd EUROCORD workshop". Bone Marrow Transplant, 1998, 22 (Suppl. 1), S22.

[8] Hows J.M.,B radleyB . A., Marsh J. C. W., Luft T., Coutinho L., Testa N. G. et al.: "Growth of human umbilical-cord blood in longterm haematopoietic cultures". Lancet, 1992, 340, 73.

[9] PiacibelloW.,S anavio F.,G aretto L.,S everino A.,B ergandi D.,F errario J., Fagioli F. et al.: "Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood". Blood, 1997, 89, 2644.

[10] Emerson S. G.: "Ex vivo expansion of hematopoietic precursors, progenitors and stem cells: the next generation of cellular therapeutics". Blood, 1996, 87, 3082.

[11] Gratwohl A.,H ermans J.,B aldomeroH ., for the EuropeanG roup forB lood and Marrow Transplantation (EBMT): "Blood and marrow transplantation activity in Europe 1995". Bone Marrow Transplant, 1997, 19, 407.

[12] LucarelliG ., Clift R. A.,G limberti M. et al.: "Bone marrow transplantation in adult thalassemic patients". Blood,1 999,9 3, 1164.

[13] Buckley R. H., Schiff S. E., Schiff R. I. et al.: "Hematopoietic stem cell transplantation for the treatment of severe combined immunodeficicncy syndrome". N. Engl..I. Med., 1999, 340, 508.

[14] Gluckman E.,B roxmeyer H. E.,A uerbach A. D., Friedman H. S., Douglas G. W., Devergie A.,E sperouH . et al.: "Hematopoietic reconstitution in a patient with Fauconi's anemaia by means of umbilical-cord blood from an HLA-identical sibling". New. Engl. J. Med., 1989, 321, 1174.

[15] Wagner J.E., Kernan N. A., SteinbruchM .,B roxmeyer H. E.,G luckmanE .: " Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease". Lancet, 1995, 346, 214.

[16] Gluckman E., Rocha V.,B oyer-Chammard A., Locatelli F.,A rcese W.,P asquini R., Ortega J. et al.: " Outcome of cord-blood transplantation from related and unrelated donors". N. Engl. J. Med., 1997, 337, 373.

[17] Rubinstein P., Carmelita C., Scaradavou A., Kurtzberg J., Adamson J., Migliacco A. R.,B erkowitz R. L. et al.: " Outcomes among 562 recipients of placental-blood transplants from unrelated donors". New Engl. J. Med., 1998, 339, 1565.

[18] Bankhead C.:" Cord blood's role in cancer therapy awaits answers". J. Natl. Cancer Inst.,1 997,8 9, 190.

[19] Silberstein L. E., Jefferies L. C.: "Placental-blood banking - a new frontier in transfusion medicine". N. Engl. J. Med., 1997, 335, 199.

[20] Gluckman E., Rocha V., Chastang C.: "Cord blood banking and transplant in Europe" Vox Sang, 1998, 74 (Suppl. 2), 95.

[21] Kurtzberg J.. Laughlin M., Graham M. L., Smith C., Olson J. F, Halperin E. C., Ciocci G. et al.: "'Placental blood as a source of hematopo,etic stem cells for transplantation into unrelated recipients". N. Engl. J. Med., 1996, 335, 157.

[22] Gruenwald P.: "The amount of fetal blood remaining in the placenta at birth". Proc. Soc. Exp. Biol. Med., 1969, 130, 326.

[23] Yao A. C., Moinian M., Lind J.: "Distribution of blood between infant and placenta after birth". Lancet, 1969, 11, 871.

[24] Peltonen T.: "Placental transfusion - Advantage and disadvantage". Eur. J. Pediatr., 1981, 137, 141.

[25] Kinmond S., Aitchison T. C., Holland B. M., Jones J. G., Turner T. L., Wardrop C. A. J.: "Umbilical cord clamping and preterm infants: a randomisedtrial". B. M. J., 1993, 306, 172.

[26] Hume H.: "Red blood cell transfusion for preterm neonates: the role of evidence-based medicine". Semin Perinatol., 1997, 21, 8.

[27] Bertolini F., Battaglia M., De Julio C., Sirchia G., Rosti L.: "Placental blood collecti on: effects on newborns". Blood, 1995, 85, 3361.

[28] Ende N.: "Cord blood collection: Effects on newborns (medico-legal)". Blood, 1995, 86, 4699.

[29] "FIGO committee report from the FIGO committee for the ethical aspects of human reproduction and women's health". Int. J. Gynecol. Obstet., 1999, 64, 317.

[30] McCullough J.. Clay M. E., Fautsch S., Noreen H., Segall M.. Perry E., Stroncek D.: "Proposed policies and procedures for the establishment of a cord blood bank". Blood Cells, 1994, 20, 609.

[31] Bertolini F, Lazzari L., Lauri E., Corsini C., Castelli C., Gorini F, Sirchia G.: "Comparative study of different procedures for the collection and banking of umb巾cal cord blood". J. Hema/other, 1995, 4, 29.

[32] Bertolini F, Battaglia M., Ziberia C., Baroni G., Soro V., Perotti C., Salvaneschi L., Robustelli della Cuna G.: "A new method for placental/cord blood processing in the collection bag. Analysis of factors involved in red blood cell removal". Bone Marrow Transplant, 1996, 18, 783.

[33] Turner C. W., Luzins J., Hutcheson C.: "A modified harvest technique for cord blood hematopoietic stem cells". Bone Marrow Transplant, 1992, 10, 89.

[34] Elchalal U., Fasouliotis S. J., Shtockheim D., Brautbar C., Schenker J. G., Wein、tcin D., Nagler A.: "Postpartum umb山cal cord blood collection for transplantation:a comparison of three methods". Am. J. Ohstet. Gynecol., 2000, 182, 227.

[35] Surbek D. V, Schonfeld B., Tichelli A., Gratwohl A., Holzgreve W.: "Optimizing umbilical cord blood mononuclear cell yield for haematopoietic stem cell transplantation:A randomized comparison of collection before vs. after placenta delivery". Bone Marrow Transplant, 1998, 22, 311.

[36] Surbek D. V, Visca E., Steinmann C., Tichelli A., Schatt S.. Hahn S., Gratwohl A., Holzgreve W.: "Umbilical cord blood collection before placental delivery during cesarean section increases cord blood volume and nucleated cell number available for transplantation". Am. J. Ohstet Gynecol., 2000, 183, 218.

[37] Giacalone P. L., Vignal J., Daures J. P., Boulot P., Hedon B., Laffargue F: "A randomized evaluation of two techniques of management of the third stage of labour in women at low risk of postpartum hemorrhage". BIOG, 2000, 107, 396.

[38] Surbek D. V., Holzgreve W., Jansen W., Heim D., Garritsen H., Nissen C., Wodnar-Filipowicz A.: "Quantitative immunophcnotypic characle raization,cryopreservation, and enrichment of second and third trimester human fetal cord blood hematopoietic stem cells (progenitor cells)" Am. J. Ohstet. Gynecol., 1998, 179, 1228.

[39] Wyrsch A., Daile Carbonare V., Jasen W., Chklovskaia E., Nissen C., Suberk D., Holzgreve W. et al.: "Preterm umbilical cored blood 1s ennched in early hematopoietic progenitors with expansion properties equal to term cord blood progenitors". Exp. Hematol., 1999, 27, 1338.

[40] Hall J. M., Lingenfeltern P., Adamns S. L., Lasser D., Hansen J. A., Bean M. A.: "Detection of maternal cells in luman umb山cal cord blood using fluorescence in situ hybridization". Blood, 1995, 86, 2829.

[41] Scaradavou A., Carrier C., Mollen N., Stevens C., Rubinstein P.: "Detection of maternal DNA in placental/umbilical cord blood by locus-spccific amplification of the noninherited maternal HLA gene". Blood, 1996, 88, 1494.

[42] Lo E. S. F., Lo Y. M. D., Hjelm N. M., Thilaganathan B.: "Transfer of nucleated maternal cells into fetal circulation during the second trimester of pregnancy". Br. J. Haematol., 1998, 100, 605.

[43] Holzgreve W., Ghezzi F., Di Naro E., Ganshirt D., Maymon E., Hahn S.: "Disturbed feto-maternal cell traffic in precolampsia". Ohstet Gynecol., 1998, 91, 669.

[44] Lind S. E.: "Ethical considerations related to the collection and distribution of cord blood stem cells for transplantation to reconstitute hematopoietic function". Transfusion, 1994, 34, 828.

[45] Marshall E.: "Clinical promise, ethical quandary". Science, 1996, 271, 586.

[46] Sugarman J., Kaalund V., Kodish E., Marshall M. F., Reisner E. G., Wilfond B. S., Wolpe P. R.: "Ethical issues in umbilical cord blood banking". JAMA, 1997, 278, 938.

[47] Zilberstein M., Feingold M., Seibel M. M.: "Umbilical-cord-blood banking: lessons learned from gamete donation". Lancet, 1997, 349, 642.

[48] Burgio G. R., Locatelli F.:'Transplant of bone marrow and cord blood hematopoietic stem cells in pediatric practice, revisited according to the fundamental principles of bioethics". Bone Marrow Transplant, 1997, 19, 1163.

[49] Surbek D. V., Islebe A, Schonfeld B., Tichelli A, Gratwhol A.. Holzgreve W.: "Attitudes of pregnant women to urnbilical cord blood donation for transplanation". Schweiz Med. Wochenschr, 1998, 128, 689.

[50] Fishman R. H. B.:" Frozen cord blood used for human gene therapy". Lancet, 1997, 349, 705.

[51] Kohn D. B., Hershfield M. S., Carbonaro D., Shigeoka A., Brooks J., Smogorzewka E. M., Barsky L. W. et al.: T lymhpocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates" Nature Med., 1998, 4, 775.

[52] Cavazzana-Calvo M., Hacein-Bey S., de Saint Basile G. et al.: "Gene therapy of human severe combined immunodeficiency (SCID)-Xl disease". Science, 2000, 288, 699.

[53] Buckley R. H.: "Gene therapy for human SCIO: dreams become relity". Nat. Med., 2000, 6, 623.

[54] Brenner M.: "Gene transfer to hematopoietic cells". New Engl. J. Med., 1996, 335, 337.

[55] Anderson W. F.: "Human gene therapy". Nature, 1998, 392 (Suppl.), 25.

[56] Pollok K. E., Hanenberg H., Noblitt T. W., Schroeder W., Kato I., Emanuel D., Williams D.: "High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments". J. Virol., 1998, 72, 4882.

[57] Schilz A. J., Brouns G., Kniiss H., Ottmann 0. G., Hoelzer D., Fauser A. A., Thrasher A. J., Grez M.: "High efficiency gene transfer to human hematopoietic SCIO-repopulating cells under 、crum-free conditions". Blood, 1998, 92, 3163.

[58] Abonour R., Williams D. A., Einhorn L. et al.: "Efficient retrovirus－mediated transfer of the multi drug resistance I gene into autologous human long-term repopulating hematopoietic stem cells“ Nat. Med., 2000, 6, 652.

[59] Uchida N., Sutton R. E., FrieraA. M., He D., Reitsma M. J., Chang W. C., Veres G. et al.: "HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated GO/GI human hematopoietic stem cells". Proc. Natl. Acad. Sci., USA 1998, 95, 11939.

[60] Miyoshi H., Smith K. A., Mosier D. E., Verma I. M., Torbett B. E.: "Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors". Science, 1999, 283, 682.

[61] Lazarus H. M.: "Hematopoietic progenitor cell transplantation in breast cancer: current status and future directions". Cancer Invest., 1998, 16, 102.

[62] Antman K. H., Rowlings P. A., Vaughan W. P. et al.: "High-dose chemotherapy with autologous hematopoietic stem cell support for breast cancer in North America". J. Clin. Oncol., 1997, 15, 1870.

[63] Fields K. K., Elfenbein G. J., Trudeau W. L. et al.: " Clini inical significance of bone marrow metastases in patients with breast cancer undergomg high-dose chemotherapy and autologous bone marrow transplantantion". J. Clin. Oncol., 1996, 14, 1868.

[64] Cooper B. W., Moss T. J., Ross A. A., Ybanez J., Lazarus H. M.: " Occult tumor contamination of hematopoietic stem cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer". J. Clin. Oncol., 1998, 16, 3509.

[65] Mapara M. Y., Korner I. S., Hildebrandt M. et al.: "Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase polymerase chain reaction". Blood, 1997, 89, 337.

[66] Eibl B., Schwaighofer H., Nachbaur D. et al.: "Evidence for•graft-versus-tumor effect in a patient treated with marrow-ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer". Blood, 1996, 88, 1501.

[67] Ueno N. T., Rondon G., Mirza N. Q. et al.: "Allogeneic peripheral blood progenitor cell transplantation for poor-risk patients with metastatic breast cancer". J. Clin. Oncol., 1998, 16, 986.